|
시장보고서
상품코드
2024954
G-단백질 결합 수용체(GPCR) 시장 규모, 점유율, 동향 및 예측 : 제품 유형별, 어세이 유형별, 용도별, 지역별(2026-2034년)G-Protein Coupled Receptors (GPCRs) Market Size, Share, Trends and Forecast by Product, Assay Type, Application, and Region, 2026-2034 |
||||||
2025년 세계의 G-단백질 결합 수용체(GPCR) 시장 규모는 38억 달러로 평가되었습니다. 향후, IMARC Group은 2034년까지 시장 규모가 60억 달러에 이르고, 2026-2034년에 걸쳐 CAGR 4.98%를 나타낼 것으로 예측했습니다. 북미가 시장을 주도하고 있으며, 2025년에는 40.3% 이상의 높은 시장 점유율을 차지했습니다. 북미는 제약 부문의 강력한 R&D 투자, 주요 생명공학 기업의 존재, 만성 질환의 유병률 증가로 인해 G-단백질 결합 수용체(GPCR) 시장을 주도했습니다. 첨단 헬스케어 인프라와 지원적인 규제 프레임워크는 신약개발과 GPCR을 표적으로 하는 치료제 개발 측면에서 이 지역의 G-단백질 결합 수용체(GPCR) 시장 점유율 확대에 더욱 기여했습니다.
G-단백질 결합 수용체(GPCR)는 인간 유전체에 의해 암호화되어 있는 가장 큰 단백질 군입니다. 이들은 세포에 신호를 전달하는 신호전달 분자로 세포 외 자극을 세포 내 반응으로 전환하는 데 중요한 역할을 합니다. 이들은 세포막에 위치하며 모든 생리적 과정을 담당하고 있습니다. GPCR은 지질, 당, 빛 에너지, 펩타이드, 단백질 등의 메시지를 받아들이는 '수신함'과 같은 역할을 하는 세포 표면의 수용체다. 이들 수용체는 염증성 질환, 대사 이상, 심장질환, 암, 단일 유전자 질환 등 다양한 질환의 치료에 널리 이용되고 있습니다. 그 결과, GPCR은 포유류, 식물, 미생물, 무척추동물을 포함한 많은 생물의 세포막에도 존재합니다.
G-단백질 결합 수용체(GPCR) 시장 동향
세계적으로 신약 개발에 GPCR의 채택이 증가하고 있는 것이 시장 성장을 이끄는 주요 요인 중 하나입니다. 이에 따라 암 환자 수 증가와 심혈관 질환, 호흡기 질환 등 생활습관병 증가로 인해 신약 개발에 GPCR이 널리 활용되고 있는 것이 시장 성장을 견인하고 있습니다. 또한, GPCR은 세포 표면에 위치하기 때문에 다양한 화학적 또는 생물학적 약물에 의해 조절이 가능하며, 여러 생리적 과정에 광범위하게 적용되고 있다는 점도 시장 성장을 가속하는 또 다른 요인으로 작용하고 있습니다. 이와 더불어, 치료제 생산 능력을 향상시키기 위해 신약 스크리닝 절차에 자동화 및 혁신 기술을 통합하는 것도 시장 성장의 원동력이 되고 있습니다. 또한, 수용체 구조의 최적화 및 신약의 제형화를 위한 전산적 방법의 발전과 같은 효과적인 신약 개발 방법의 획기적인 발전이 시장 성장을 가속하고 있습니다. 또한 종양학, 침윤, 전이, 이동, 혈관 재형성 등 암 생물학의 다양한 측면에서 GPCR이 광범위하게 채택되면서 시장 성장에 큰 탄력을 받고 있습니다. 이와 더불어 전이 및 종양 증식 규명, 효과적인 치료법 개발을 위한 GPCR의 활용 확대가 시장 성장에 긍정적인 영향을 미치고 있습니다. 또한, 광범위한 연구개발(R&D) 활동, 다양한 자동화 기술 향상, 순환 아데노신 모노포스페이트(cAMP)의 보급, 생명공학 및 바이오 의약품 부문에서 다양한 정부 주도 이니셔티브의 시행 등이 시장 성장을 견인할 것으로 예측됩니다.
본 보고서에서 답변을 얻을 수 있는 주요 질문
- 지금까지의 세계의 G-단백질 결합 수용체(GPCR) 시장 동향은 어떠했으며, 향후 몇 년 동안 어떻게 변화할 것인가?
- 세계의 G 단백질 결합 수용체(GPCR) 시장 성장 촉진요인, 억제요인 및 기회는?
- 주요 지역 시장은?
- G 단백질 결합 수용체(GPCR) 시장에서 가장 매력적인 국가는 어디인가?
- 제품별로 보면, 시장 분석은 어떻게 이루어지나요?
- 분석 유형별 시장 분석은 어떻게 이루어지고 있는가?
- 용도에 따른 시장 내역은?
- 세계의 G-단백질 결합 수용체(GPCR) 시장 경쟁 구도는 어떤가?
- 세계 G-단백질 결합 수용체(GPCR) 시장의 주요 시장 진출기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 G-단백질 결합 수용체(GPCR) 시장
제6장 시장 분석 : 제품별
제7장 시장 분석 : 어세이 유형별
제8장 시장 분석 : 용도별
제9장 시장 분석 : 지역별
제10장 성장 촉진요인, 억제요인 및 기회
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KTH 26.05.15The global G-protein coupled receptors (GPCRs) market size was valued at USD 3.8 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 6.0 Billion by 2034, exhibiting a CAGR of 4.98% during 2026-2034. North America dominated the market, holding a significant market share of over 40.3% in 2025. North America led the GPCRs market due to strong pharmaceutical R&D investment, the presence of major biotech companies, and the rising prevalence of chronic diseases. Advanced healthcare infrastructure and supportive regulatory frameworks further contributed to the region's G-protein coupled receptors (GPCRs) market share in both drug discovery and GPCR-targeted therapeutics development.
G-protein-coupled receptors (GPCRs) are the largest protein family encoded by the human genome. They are signal-transducing molecules that transmit signals to cells and play a key role in converting an extracellular stimulus into intracellular responses. They are located in the cell membrane and are responsible for all physiological processes. GPCRs are cell surface receptors that act like an inbox for messages in the form of lipids, sugars, light energy, peptides, and proteins. These receptors are widely used in the treatment of various diseases, such as inflammatory disorders, metabolic imbalances, cardiac disorders, cancer, and monogenic disorders. As a result, GPCRs are also found in the cell membranes of several organisms, including mammals, plants, microorganisms, and invertebrates.
G-Protein Coupled Receptors (GPCRs) Market Trends:
The increasing adoption of GPCRs in drug discovery across the globe is one of the key factors driving the market growth. In line with this, the widespread utilization of GPCRs in the development of novel pharmaceuticals due to the rising number of cancer cases and lifestyle-related diseases, such as cardiovascular infections and respiratory difficulties, are favoring the market growth. Moreover, the extensive application of GPCRs in several physiological processes as they can be modulated by a wide range of chemical or biological agents due to their cell-surface location is acting as another growth-inducing factor. Apart from this, the integration of automation and innovative technologies with drug development screening procedures to improve their capabilities in therapeutic production is providing an impetus to the market growth. Furthermore, significant developments in effective drug discovery methods, such as advancements in the computational approaches to streamline receptor structure and formulation of new drugs, are propelling the market growth. Additionally, the widespread adoption of GPCRs in oncology and various aspects of cancer biology, such as invasion, migration, and vascular remolding, is providing a considerable boost to the market growth. Besides this, the increasing utilization of GPCRs for decoding metastasis and growth of tumors and developing effective lines of treatment is positively influencing the market growth. Other factors, including extensive research and development (R&D) activities, various automation improvements, the widespread adoption of cyclic Adenosine Monophosphate (cAMP), and the implementation of various government initiatives in the biotechnology and biopharmaceutical sector are anticipated to drive the market growth.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each segment of the global G-protein coupled receptors (GPCRs) market, along with forecasts at the global, regional, and country level from 2026-2034. Our report has categorized the market based on product, assay type, and application.
Product Insights:
- Cell Lines
- Detection Kits
- Cell Culture Reagents
- Ligands
Assay Type Insights:
- cAMP Functional Assays
- Calcium Functional Assays
- B-Arrestin Functional Assays
- Radioligand Binding and GTPYS Functional Assays
- Internalization Assays
- Trafficking Assays
- Others
Application Insights:
- Cancer Research
- CNS Research
- Metabolic Research
- Cardiovascular Research
- Inflammation Research
- Respiratory Research
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for G-protein coupled receptors (GPCRs). Some of the factors driving the North America G-protein coupled receptors (GPCRs) market included rising number of cancer cases, extensive research and development (R&D) activities, and various automation improvements.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global G-protein coupled receptors (GPCRs) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abcam plc, Becton Dickinson and Company, Enzo Biochem Inc., Eurofins DiscoverX Products LLC, HD Biosciences Co. Ltd. (WuXi AppTec), Merck KGaA, Molecular Devices LLC (Danaher Corporation), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., etc.
Key Questions Answered in This Report:
- How has the global G-protein coupled receptors (GPCRs) market performed so far and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global G-protein coupled receptors (GPCRs) market?
- What are the key regional markets?
- Which countries represent the most attractive G-protein coupled receptors (GPCRs) markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the assay type?
- What is the breakup of the market based on the application?
- What is the competitive structure of the global G-protein coupled receptors (GPCRs) market?
- Who are the key players/companies in the global G-protein coupled receptors (GPCRs) market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global G-Protein Coupled Receptors (GPCRs) Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Cell Lines
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Detection Kits
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Cell Culture Reagents
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Ligands
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Assay Type
- 7.1 cAMP Functional Assays
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Calcium Functional Assays
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 B-Arrestin Functional Assays
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Radioligand Binding and GTPYS Functional Assays
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Internalization Assays
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Trafficking Assays
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
8 Market Breakup by Application
- 8.1 Cancer Research
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 CNS Research
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Metabolic Research
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Cardiovascular Research
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Inflammation Research
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Respiratory Research
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
- 8.7 Others
- 8.7.1 Market Trends
- 8.7.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
- 10.1 Overview
- 10.2 Drivers
- 10.3 Restraints
- 10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abcam plc
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Becton Dickinson and Company
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Enzo Biochem Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Eurofins DiscoverX Products LLC
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 HD Biosciences Co. Ltd. (WuXi AppTec)
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.6 Merck KGaA
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Molecular Devices LLC (Danaher Corporation)
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 PerkinElmer Inc.
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Promega Corporation
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.10 Thermo Fisher Scientific Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.1 Abcam plc
